108 related articles for article (PubMed ID: 14552454)
1. Dementia: new theories, new treatments.
Penix LP
Ethn Dis; 2003; 13(3 Suppl 3):S3-54-5. PubMed ID: 14552454
[No Abstract] [Full Text] [Related]
2. Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease.
Zec RF; Burkett NR
NeuroRehabilitation; 2008; 23(5):425-38. PubMed ID: 18957729
[TBL] [Abstract][Full Text] [Related]
3. [Approach to the rational management of patients with dementia].
Six P
Schweiz Rundsch Med Prax; 1991 Jul; 80(27-28):746-9. PubMed ID: 1862266
[TBL] [Abstract][Full Text] [Related]
4. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
Stavitsky K; Brickman AM; Scarmeas N; Torgan RL; Tang MX; Albert M; Brandt J; Blacker D; Stern Y
Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
[TBL] [Abstract][Full Text] [Related]
5. Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
Frankfort SV; Appels BA; De Boer A; Tulner LR; Van Campen JP; Koks CH; Beijnen JH
Int J Clin Pract; 2006 Jun; 60(6):646-54. PubMed ID: 16805746
[TBL] [Abstract][Full Text] [Related]
6. When should patients with Alzheimer disease stop driving?
Erten-Lyons D
Neurology; 2008 Apr; 70(14):e45-47. PubMed ID: 18378878
[No Abstract] [Full Text] [Related]
7. Behavioral symptoms in residential care/assisted living facilities: prevalence, risk factors, and medication management.
Gruber-Baldini AL; Boustani M; Sloane PD; Zimmerman S
J Am Geriatr Soc; 2004 Oct; 52(10):1610-7. PubMed ID: 15450035
[TBL] [Abstract][Full Text] [Related]
8. Behavior as an efficacy outcome.
Cummings JL
Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():v-vi. PubMed ID: 9339265
[No Abstract] [Full Text] [Related]
9. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of Alzheimer's disease treatments.
Davis JB; Bountra C; Richardson J
Handb Clin Neurol; 2008; 89():273-90. PubMed ID: 18631752
[No Abstract] [Full Text] [Related]
11. [Psychobehavioral disorders in severe dementia].
Derouesné C
Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S5-13. PubMed ID: 15899600
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease.
Francis PT
Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401
[TBL] [Abstract][Full Text] [Related]
13. [Challenging pharmacotherapy in dementia].
Ihl R
MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
[No Abstract] [Full Text] [Related]
14. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
15. Toward optimal health: the experts discuss memory loss in aging women.
Espino DV; Andel R
J Womens Health (Larchmt); 2004 Oct; 13(8):856-62. PubMed ID: 15671701
[No Abstract] [Full Text] [Related]
16. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
[TBL] [Abstract][Full Text] [Related]
17. Azelastine hydrochloride on behavioral and psychological symptoms and activities of daily living in dementia patients.
Hatakeyama A; Fujii M; Hatakeyama R; Fukuoka Y; Satoh-Nakagawa T; Sasaki H
Geriatr Gerontol Int; 2008 Mar; 8(1):59-61. PubMed ID: 18713191
[No Abstract] [Full Text] [Related]
18. [Behavioural and psychological symptoms in dementia in Alzheimer's disease].
Benoit M; Robert P
Rev Prat; 2005 Nov; 55(17):1895-901. PubMed ID: 16396230
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
20. Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale.
Belanger HG; Wilder-Willis K; Malloy P; Salloway S; Hamman RF; Grigsby J
Arch Clin Neuropsychol; 2005 Mar; 20(2):183-9. PubMed ID: 15708728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
